[Federal Register Volume 79, Number 194 (Tuesday, October 7, 2014)]
[Notices]
[Page 60501]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-23828]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Meda 
Pharmaceuticals, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Meda Pharmaceuticals, Inc., applied to be registered as an 
importer of a certain basic class of controlled substance. The DEA 
grants Meda Pharmaceuticals, Inc., registration as an importer of this 
controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated June 10, 2014, and published 
in the Federal Register on June 17, 2014, 79 FR 34552, Meda 
Pharmaceuticals, Inc., 705 Eldorado Street, Decatur, Illinois 62523, 
applied to be registered as an importer of a certain basic class of 
controlled substance. No comments or objections were submitted for this 
notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of Meda Pharmaceuticals, Inc., to import the basic class 
of controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of nabilone (7379), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the FDA approved listed controlled 
substance as a finished drug product in dosage form for distribution to 
its customers.

    Dated: September 26, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-23828 Filed 10-6-14; 8:45 am]
BILLING CODE 4410-09-P